Effects of Suvorexant in Patients With Chronic Obstructive Pulmonary Disease (MK-4305-032)
Clinical trial NCT01293006 · COMPLETED
Trial details
- NCT number
- NCT01293006
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-25
- Primary completion
- 2012-01-20
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.